These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 33230782)
41. SFRP1 promoter methylation and expression in human trabecular meshwork cells. Mao W; Rubin JS; Anoruo N; Wordinger RJ; Clark AF Exp Eye Res; 2012 Apr; 97(1):130-6. PubMed ID: 22248913 [TBL] [Abstract][Full Text] [Related]
42. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Dong SM; Kim HS; Rha SH; Sidransky D Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914 [TBL] [Abstract][Full Text] [Related]
43. Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancer. Zhang YW; Miao YF; Yi J; Geng J; Wang R; Chen LB Neoplasma; 2010; 57(3):228-33. PubMed ID: 20353273 [TBL] [Abstract][Full Text] [Related]
44. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India. Siddiqui S; Akhter N; Deo SV; Shukla NK; Husain SA Breast Cancer; 2016 Nov; 23(6):922-931. PubMed ID: 26754093 [TBL] [Abstract][Full Text] [Related]
45. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients. Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937 [TBL] [Abstract][Full Text] [Related]
46. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099 [TBL] [Abstract][Full Text] [Related]
47. APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients. Saelee P; Pongtheerat T Asian Pac J Cancer Prev; 2020 Dec; 21(12):3627-3632. PubMed ID: 33369461 [TBL] [Abstract][Full Text] [Related]
48. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis. Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446 [TBL] [Abstract][Full Text] [Related]
49. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650 [TBL] [Abstract][Full Text] [Related]
50. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816 [TBL] [Abstract][Full Text] [Related]
51. Promoter Methylation and Relative mRNA Expression of the p16 Gene in Cervical Cancer in North Indians. Gupta A; Ahmad MK; Mahndi AA; Singh R; Pradeep Y Asian Pac J Cancer Prev; 2016; 17(8):4149-54. PubMed ID: 27644676 [TBL] [Abstract][Full Text] [Related]
52. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer. Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728 [TBL] [Abstract][Full Text] [Related]
53. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055 [TBL] [Abstract][Full Text] [Related]
54. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994 [TBL] [Abstract][Full Text] [Related]
55. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Wisman GB; Nijhuis ER; Hoque MO; Reesink-Peters N; Koning AJ; Volders HH; Buikema HJ; Boezen HM; Hollema H; Schuuring E; Sidransky D; van der Zee AG Int J Cancer; 2006 Oct; 119(8):1908-14. PubMed ID: 16736496 [TBL] [Abstract][Full Text] [Related]
56. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis. Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891 [TBL] [Abstract][Full Text] [Related]
57. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients. Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611 [TBL] [Abstract][Full Text] [Related]
58. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Deng G; Song GA; Pong E; Sleisenger M; Kim YS Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381 [TBL] [Abstract][Full Text] [Related]
59. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815 [TBL] [Abstract][Full Text] [Related]
60. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]